This company has been marked as potentially delisted and may not be actively trading. Kiromic BioPharma (KRBP) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisEarningsHeadlinesShort InterestTrendsBuy This Stock Kiromic BioPharma Short Interest DataKiromic BioPharma (KRBP) has a short interest of 200 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 11,347 shares to cover all short positions.Current Short Interest200 sharesPrevious Short Interest200 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$234.56Short Interest Ratio0.3 Days to CoverLast Record DateMarch 14, 2025Outstanding Shares1,571,000 sharesPercentage of Shares Shorted0.01%Today's Trading Volume107,749 sharesAverage Trading Volume11,347 sharesToday's Volume Vs. Average950% Short Selling Kiromic BioPharma? Sign up to receive the latest short interest report for Kiromic BioPharma and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKRBP Short Interest Over TimeKRBP Days to Cover Over TimeKRBP Percentage of Float Shorted Over Time Kiromic BioPharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/14/2025200 shares $234.56 No ChangeN/A0.3 $1.17 2/14/2025200 shares $300.00 -80.0%N/A0.1 $1.50 1/31/20251,000 shares $899.90 +400.0%N/A0.2 $0.90 1/15/2025200 shares $185.00 No ChangeN/A0.2 $0.93 8/31/202345,700 shares $81.80 thousand -8.2%4.0%0.6 $1.79 8/15/202349,800 shares $117.53 thousand -20.2%4.4%0.5 $2.36 7/31/202362,400 shares $153.50 thousand -20.6%5.5%0.4 $2.46 7/15/202378,600 shares $239.73 thousand +165.5%6.9%0.3 $3.05 6/30/202329,600 shares $80.51 thousand -28.3%2.6%0.1 $2.72 6/15/202341,300 shares $143.31 thousand +21.5%3.7%0.1 $3.47 Get the Latest News and Ratings for KRBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kiromic BioPharma and its competitors with MarketBeat's FREE daily newsletter. 5/31/202334,000 shares $107.78 thousand +5.6%3.6%0.1 $3.17 5/15/202332,200 shares $132.34 thousand -6.9%3.4%0.1 $4.11 4/30/202334,600 shares $140.30 thousand -46.5%3.7%0.1 $4.06 4/15/202364,700 shares $302.15 thousand +7.5%7.0%0.4 $4.67 3/31/202360,200 shares $232.38 thousand +78.6%9.4%0.5 $3.86 3/15/202333,700 shares $143.23 thousand -87.4%5.3%0.4 $4.25 2/28/2023267,900 shares $49.70 thousand +110.9%N/A0.1 $0.19 2/15/2023127,000 shares $20.78 thousand -61.7%N/A0.1 $0.16 1/31/2023331,700 shares $69.33 thousand +49.0%N/A0.3 $0.21 1/15/2023222,600 shares $46.79 thousand +2.2%N/A1.1 $0.21 12/30/2022217,800 shares $39.36 thousand -42.6%N/A2.1 $0.18 12/15/2022379,600 shares $91.18 thousand -25.0%N/A0.6 $0.24 11/30/2022505,800 shares $130.29 thousand -12.1%N/A0.8 $0.26 11/15/2022575,500 shares $164.08 thousand +2.6%N/A0.9 $0.29 10/31/2022561,200 shares $167.24 thousand -7.0%N/A0.6 $0.30 10/15/2022603,400 shares $200.63 thousand +45.7%N/A0.7 $0.33 9/30/2022414,200 shares $120.12 thousand -16.7%N/A0.5 $0.29 9/15/2022497,400 shares $186.53 thousand -13.7%N/A0.5 $0.38 8/31/2022576,000 shares $213.12 thousand -17.8%N/A0.8 $0.37 8/15/2022700,900 shares $325.43 thousand -3.1%N/A0.5 $0.46 7/31/2022723,000 shares $237.14 thousand +88.1%N/A0.6 $0.33 7/15/2022384,300 shares $151.80 thousand +125.8%N/A0.3 $0.40 6/30/2022170,200 shares $72.35 thousand -67.3%N/A0.1 $0.43 6/15/2022519,900 shares $201.36 thousand +384.5%N/A0.5 $0.39 5/31/2022107,300 shares $37.13 thousand +92.6%N/A0.1 $0.35 5/15/202255,700 shares $18.60 thousand -41.6%N/A0.2 $0.33 4/30/202295,400 shares $57.60 thousand -47.5%N/A0.3 $0.60 4/15/2022181,700 shares $152.17 thousand -8.2%N/A0.7 $0.84 3/31/2022198,000 shares $169.09 thousand -40.5%N/A0.7 $0.85 3/15/2022333,000 shares $238.13 thousand +216.5%N/A1.1 $0.72Google did what!?!? (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why 2/28/2022105,200 shares $72.08 thousand -13.3%N/A0.3 $0.69 2/15/2022121,300 shares $87.36 thousand +155.4%N/A0.9 $0.72 1/31/202247,500 shares $52.25 thousand -29.0%N/A0.3 $1.10 1/15/202266,900 shares $90.98 thousand +17.6%N/A0.2 $1.36 12/31/202156,900 shares $87.06 thousand -68.0%N/A0.1 $1.53 12/15/2021177,700 shares $334.08 thousand +3.3%N/A0.4 $1.88 11/30/2021172,000 shares $459.24 thousand -55.6%N/A0.4 $2.67 11/15/2021387,400 shares $1.20 million +23.2%N/A0.9 $3.11 10/29/2021314,400 shares $701.11 thousand +663.1%N/A0.7 $2.23 10/15/202141,200 shares $81.16 thousand +6.5%N/A0.1 $1.97 9/30/202138,700 shares $118.81 thousand -6.8%N/A0.1 $3.07 9/15/202141,500 shares $147.74 thousand +26.5%N/A0.1 $3.56 8/31/202132,800 shares $113.16 thousand -27.6%N/A0.1 $3.45 8/13/202145,300 shares $139.98 thousand -21.5%N/A0.2 $3.09 7/30/202157,700 shares $185.22 thousand -18.5%N/A0.2 $3.21 7/15/202170,800 shares $266.21 thousand -60.4%N/A0.4 $3.76 6/30/2021178,700 shares $859.55 thousand +392.3%2.6%1.1 $4.81 6/15/202136,300 shares $355.74 thousand -22.8%1.1%0.8 $9.80 5/28/202147,000 shares $381.64 thousand +370.0%1.4%1.1 $8.12 5/14/202110,000 shares $53 thousand +9.9%0.3%0.2 $5.30 4/30/20219,100 shares $81.54 thousand -27.8%0.4%0.5 $8.96 4/15/202112,600 shares $118.31 thousand +23.5%0.6%0.6 $9.39 3/31/202110,200 shares $95.98 thousand +22.9%0.7%0.5 $9.41 3/15/20218,300 shares $89.39 thousand +25.8%0.5%0.2 $10.77 2/26/20216,600 shares $72.01 thousand +120.0%0.4%0.1 $10.91 2/12/20213,000 shares $31.50 thousand -36.2%0.2%0 $10.50 1/29/20214,700 shares $42.30 thousand +42.4%0.3%0.1 $9.00 1/15/20213,300 shares $27.72 thousand No Change0.2%0.1 $8.40 KRBP Short Interest - Frequently Asked Questions What is Kiromic BioPharma's current short interest? Short interest is the volume of Kiromic BioPharma shares that have been sold short but have not yet been closed out or covered. As of March 14th, investors have sold 200 shares of KRBP short. Learn More on Kiromic BioPharma's current short interest. How does Kiromic BioPharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kiromic BioPharma: Sorrento Therapeutics, Inc. (0.65%), ZyVersa Therapeutics, Inc. (8.60%), Evofem Biosciences, Inc. (0.00%), Vaccinex, Inc. (0.16%), Salarius Pharmaceuticals, Inc. (10.59%), Petros Pharmaceuticals, Inc. (4.05%), Bio-Path Holdings, Inc. (0.13%), Panbela Therapeutics, Inc. (0.00%), Biophytis S.A. (0.21%), Hepion Pharmaceuticals, Inc. (0.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Domino's Pizza Inc ($736.25 million), The Campbell's Company ($649.30 million), Science Applications International Co. ($285.09 million), Brookfield Infrastructure Co. ($244.13 million), Renasant Co. ($199.30 million), Dream Finders Homes, Inc. ($153.47 million), Xerox Holdings Co. ($145.39 million), First Advantage Co. ($78.80 million), Zymeworks Inc. ($66.40 million), and Kforce Inc. ($53.83 million). View all of the most shorted stocks. What does it mean to sell short Kiromic BioPharma stock? Short selling KRBP is an investing strategy that aims to generate trading profit from Kiromic BioPharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kiromic BioPharma? A short squeeze for Kiromic BioPharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KRBP, which in turn drives the price of the stock up even further. How often is Kiromic BioPharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRBP, twice per month. The most recent reporting period available is March, 14 2025. More Short Interest Resources from MarketBeat Related Companies SRNE Short Interest ZVSA Short Interest EVFM Short Interest VCNX Short Interest SLRX Short Interest PTPI Short Interest BPTH Short Interest PBLA Short Interest BPTSY Short Interest HEPA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KRBP) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kiromic BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kiromic BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRBP Stock Alerts